openPR Logo
Press release

Plantar Fasciitis Pipeline Analysis, Clinical Trials, 2025 | Plantar Fasciitis Treatment Market by DelveInsight | Mimedx, Revance Therapeutics

04-28-2025 09:22 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Plantar Fasciitis Pipeline Insights, 2025

Plantar Fasciitis Pipeline Insights, 2025

Plantar Fasciitis Pipeline constitutes 3+ key companies continuously working towards developing 3+ Plantar Fasciitis treatment therapies, analyzes DelveInsight.
Plantar Fasciitis Disease Overview:

Plantar fasciitis is one of the most common reasons for heel pain. The plantar fascia is a thick, web-like ligament that links the heel bone to the front of the foot. It plays a crucial role in walking by acting as a shock absorber and supporting the foot's arch. Over time, daily activities can cause significant strain on this ligament, leading to inflammation, which results in heel pain and stiffness.

Download our report @ https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

"Plantar Fasciitis Pipeline Insight 2025 [https://www.delveinsight.com/sample-request/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Plantar Fasciitis Therapeutics Market.

Key Takeaways from the Plantar Fasciitis Pipeline Report

*
DelveInsight's Plantar Fasciitis pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Plantar Fasciitis treatment.

*
The FDA expanded ActiPatch Registered 's OTC clearance to encompass general musculoskeletal pain, broadening its application beyond specific conditions.

*
The FDA granted 510(k) clearance for Erchonia's FX 635 low-level laser device for the temporary relief of chronic musculoskeletal pain. This clearance was based on clinical trials demonstrating significant pain reduction in patients.

*
Key Plantar Fasciitis companies such as Mimedx, Revance Therapeutics, and others are evaluating new drugs for Plantar Fasciitis to improve the treatment landscape.

*
Promising Plantar Fasciitis therapies are Micronized dHCAM, DAXI, and others.

Plantar Fasciitis Pipeline Analysis

The Plantar Fasciitis pipeline insights report 2025, provides insights into:

*
Provides comprehensive insights into key companies developing therapies in the Plantar Fasciitis Market.

*
Categorizes Plantar Fasciitis therapeutic companies by development stage: early, mid, and late-stage.

*
Highlights major companies involved in targeted therapy development, including both active and inactive (paused/discontinued) projects.

*
Reviews emerging Plantar Fasciitis drugs under development based on:

*
Stage of development

*
Plantar Fasciitis Route of administration

*
Target receptor

*
Monotherapy vs. combination therapy

*
Plantar Fasciitis Mechanism of action

*
Molecular type

*
Offers detailed analysis of:

*
Company-to-company and company-academia collaborations

*
Plantar Fasciitis Licensing agreements

*
Funding and investment activities supporting future Plantar Fasciitis market advancement.

Request for a sample report @ https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Plantar Fasciitis Emerging Drugs

*
Micronized dHCAM: Mimedx

*
DAXI: Revance Therpaeutics

Plantar Fasciitis Companies

Around three major companies are currently developing therapies for Plantar Fasciitis. Among them, Mimedx and a few others have drug candidates in the mid to late stages of development, specifically in Phase II and Phase III clinical trials.

DelveInsight's report covers around 140+ products under different phases of Plantar Fasciitis clinical trials [https://www.delveinsight.com/sample-request/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] like

*
Plantar Fasciitis Late stage Therapies (Phase III)

*
Plantar Fasciitis Mid-stage Therapies (Phase II)

*
Plantar Fasciitis Early-stage Therapies (Phase I)

*
Plantar Fasciitis Pre-clinical and Plantar Fasciitis Discovery stage Therapies

*
Plantar Fasciitis Discontinued & Inactive Therapies

Plantar Fasciitis pipeline report provides the Plantar Fasciitis therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

*
Intravenous

*
Subcutaneous

*
Oral

*
Intramuscular

Plantar Fasciitis Products have been categorized under various Molecule types such as

*
Monoclonal antibody

*
Small molecule

*
Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Plantar Fasciitis Therapies and Key Plantar Fasciitis Companies: Plantar Fasciitis Clinical Trials and recent advancements [https://www.delveinsight.com/report-store/plantar-fasciitis-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Plantar Fasciitis Pipeline Therapeutic Assessment

- Plantar Fasciitis Assessment by Product Type

- Plantar Fasciitis By Stage

- Plantar Fasciitis Assessment by Route of Administration

- Plantar Fasciitis Assessment by Molecule Type

Table of Content

1. Report Introduction

2. Executive Summary

3. Plantar Fasciitis Current Treatment Patterns

4. Plantar Fasciitis - DelveInsight's Analytical Perspective

5. Therapeutic Assessment

6. Plantar Fasciitis Late-Stage Products (Phase-III)

7. Plantar Fasciitis Mid-Stage Products (Phase-II)

8. Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Plantar Fasciitis Discontinued Products

13. Plantar Fasciitis Product Profiles

14. Plantar Fasciitis Key Companies

15. Plantar Fasciitis Key Products

16. Dormant and Discontinued Products

17. Plantar Fasciitis Unmet Needs

18. Plantar Fasciitis Future Perspectives

19. Plantar Fasciitis Analyst Review

20. Appendix

21. Report Methodology

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=plantar-fasciitis-pipeline-analysis-clinical-trials-2025-plantar-fasciitis-treatment-market-by-delveinsight-mimedx-revance-therapeutics]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Plantar Fasciitis Pipeline Analysis, Clinical Trials, 2025 | Plantar Fasciitis Treatment Market by DelveInsight | Mimedx, Revance Therapeutics here

News-ID: 3991381 • Views:

More Releases from ABNewswire

McKayLawTx.com Achieves Highest Client Satisfaction Ratings in East Texas with Over 350 Five-Star Google Reviews
McKayLawTx.com Achieves Highest Client Satisfaction Ratings in East Texas with O …
McKay Law Innovative Client Service Model Combining Weekly Communication, Free Property Damage Representation, Settlement Advances, and Complimentary Medical Transportation Drives Unprecedented Client Satisfaction. Mandatory Weekly Client Communication; Research-backed 40-60% satisfaction increase; Free Property Damage Representation; $2,000-$8,000 additional recovery typical; Complete representation without separate fees; SULPHUR SPRINGS, TX - McKay Law PLLC, East Texas's premier personal injury law firm, has been recognized as the region's top-rated legal practice based on exceptional client
Manhattan Child Custody and Visitation Attorney Richard Roman Shum Clarifies Sole Custody and Visitation Rights in New York
Manhattan Child Custody and Visitation Attorney Richard Roman Shum Clarifies Sol …
New York, NY - Manhattan child custody and visitation attorney Richard Roman Shum of the Law Office of Richard Roman Shum, Esq. (https://www.romanshum.com/if-i-have-sole-custody-do-i-have-to-allow-visitation/) is highlighting how New York custody and visitation laws apply when one parent has sole custody, particularly for families navigating proceedings in Manhattan Family Court. Through an in-depth informational resource titled "If I Have Sole Custody, Do I Have to Allow Visitation?", Attorney Shum explains how court
Chicago Divorce Lawyer Russell D. Knight Explains Child Support And 50/50 Custody In Illinois
Chicago Divorce Lawyer Russell D. Knight Explains Child Support And 50/50 Custod …
Chicago, Illinois - Chicago divorce lawyer Russell D. Knight of the Law Office of Russell D. Knight (https://rdklegal.com/child-support-and-50-50-custody-in-illinois) is clarifying how child support works in Illinois when parents share parenting time on an equal or near equal basis. As more Chicago families move toward 50/50 parenting schedules, questions have grown regarding how Illinois child support guidelines apply when neither parent is the clear majority time parent. Illinois courts have authority under
Elite Coaching Academy on Pace to Become First $20 Million Online Fitness Mentorship
Elite Coaching Academy on Pace to Become First $20 Million Online Fitness Mentor …
Elite Coaching Academy is accelerating toward a $20M/year trajectory, redefining the global coaching industry through worldclass physique coaching, functional health education via ECA Medical, and business mentorship that has scaled dozens of coaches to sixfigure incomes. With 4,000+ transformations and physicianlevel systems, ECA stands as the industry's elite standard. AUSTIN, Texas - Elite Coaching Academy is on track to become the first online fitness coaching mentorship to reach $20 million in

All 5 Releases


More Releases for Plantar

Top Trends Transforming the Plantar Fasciitis Treatment Market Landscape in 2025 …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Will the Plantar Fasciitis Treatment Industry Market Size Be by 2025? In the past few years, the market size for treatments of plantar fasciitis has experienced substantial growth, set to increase from $1.68 billion in 2024 to $2.08 billion in 2025 with a CAGR of 24.0%. This incredible expansion during the historical period
Plantar Plate Repair Market: Global Industry Analysis and Forecast
The global plantar plate repair market was valued at approximately USD 325 million in 2023 and is anticipated to reach USD 510 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033. The plantar plate repair market has gained significant momentum in recent years due to a rising prevalence of foot deformities, increased awareness of foot health, and advancements in minimally invasive surgical procedures. The plantar plate, a
Emerging Trends Influencing The Growth Of The Plantar Fasciitis Treatment Market …
The Plantar Fasciitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Plantar Fasciitis Treatment Market? In recent times, the market size for treating plantar fasciitis has seen an explosive growth. Its value is projected to increase from $1.68
Plantar Fasciitis Treatment Market Outlook 2024-2030
Plantar fasciitis, a common ailment among runners, hikers, and individuals with active lifestyles, as well as those who spend long hours on their feet, presents a significant market opportunity for treatment providers. With the Plantar Fasciitis Treatment Market poised to reach a valuation of US$ 1190 Mn. at a CAGR of 4.40% during the forecast period, let's unravel the dynamics shaping this burgeoning sector: Know More About The Report: https://www.maximizemarketresearch.com/market-report/global-plantar-fasciitis-treatment-market/110197/ Market Dynamics: The
Plantar Fasciitis Market Research Survey Report, 2021-2028
Plantar Fasciitis Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study. Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/15701229?utm_source=Openpr&utm_medium=Shubhamko
Plantar Fasciitis Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Plantar Fasciitis Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Plantar Fasciitis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Plantar Fasciitis Treatment with respect